Erudio Healtherudio.com
Drug
Sonrotoclax trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying sonrotoclax: BGB-11417-101. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 1 more trial with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| BGB-11417-101 NCT04277637 · BeOne Medicines | mature B-cell malignancies | Phase 1 | 133 | 27 | Focused | Nov 20, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| CELESTIAL-RRMCL NCT06742996 · BeOne Medicines FocusedView → | relapsed/refractory mantle cell lymphoma | Phase 3 | Focused | View | |||